Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Stratification of type 2 diabetes based on routine clinical markers

Research output: Contribution to journalJournal articleResearchpeer-review

  1. HbA1c variability and the development of nephropathy in individuals with type 1 diabetes mellitus from Rwanda

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Risk of diabetes among related and unrelated family members

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Effects of Dapagliflozin in Patients With Kidney Disease, With and Without Heart Failure

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

AIMS: We hypothesized that patients with dysregulated type 2 diabetes may be stratified based on routine clinical markers.

METHODS: In this retrospective cohort study, diabetes related clinical measures including age at onset, diabetes duration, HbA1c, BMI, HOMA2-β, HOMA2-IR and GAD65 autoantibodies, were used for sub-grouping patients by K-means clustering and for adjusting. Probability of diabetes complications (95% confidence interval), were calculated using logistic regression.

RESULTS: Based on baseline data from patients with type 2 diabetes (n=2,290), the cluster analysis suggested up to five sub-groups. These were primarily characterized by autoimmune β-cell failure (3%), insulin resistance with short disease duration (21%), non-autoimmune β-cell failure (22%), insulin resistance with long disease duration (32%), and presence of metabolic syndrome (22%), respectively. Retinopathy was more common in the sub-group characterized by non-autoimmune β-cell failure (52% (47.7-56.8)) compared to other sub-groups (22% (20.1-24.1)), adj. p<0.001. The prevalence of cardiovascular disease, nephropathy and neuropathy also differed between sub-groups, but significance was lost after adjustment.

CONCLUSIONS: Patients with type 2 diabetes cluster into clinically relevant sub-groups based on routine clinical markers. The prevalence of diabetes complications seems to be sub-group specific. Our data suggests the need for a tailored strategy for the treatment of type 2 diabetes.

Original languageEnglish
JournalDiabetes Research and Clinical Practice
Volume141
Pages (from-to)275-283
Number of pages8
ISSN0168-8227
DOIs
Publication statusPublished - Jul 2018

    Research areas

  • Journal Article

ID: 53789060